Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution.

[1]  R. Aspinall,et al.  Thymic Involution in Aging , 2000, Journal of Clinical Immunology.

[2]  A. Fattorossi,et al.  Membrane expression of HLA-Cw4 free chains in activated T cells of transgenic mice , 2004, Immunogenetics.

[3]  A. Fattorossi,et al.  Human CD4 produced in lymphoid cells of transgenic mice binds HIV gp120 and modifies the subsets of mouse T-cell populations , 2004, Immunogenetics.

[4]  W. Simmons,et al.  Proline specific endo- and exopeptidases , 1980, Molecular and Cellular Biochemistry.

[5]  S. Iwata,et al.  Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  B. Fleischer,et al.  Molecular analysis of CD26-mediated signal transduction in T cells. , 2000, Immunology letters.

[7]  I. De Meester,et al.  CD26, let it cut or cut it down. , 1999, Immunology today.

[8]  F. Bolognani,et al.  Homeostasis, Thymic Hormones and Aging , 1999, Gerontology.

[9]  J. Souberbielle,et al.  Growth hormone and its receptor are expressed in human thymic cells. , 1998, Endocrinology.

[10]  G. Opdenakker,et al.  Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. , 1998, Biochemistry.

[11]  P. Ruiz,et al.  Human thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny. , 1998, Clinical immunology and immunopathology.

[12]  J. Klein.  Hormone regulation of immune homeostasis: local or long distance? , 1998, Biochemical pharmacology.

[13]  T. Honjo,et al.  Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage , 1998 .

[14]  Dominique Schols,et al.  Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV , 1998, The Journal of Biological Chemistry.

[15]  B. Fleischer,et al.  Dipeptidyl‐peptidase IV/CD26 on T cells: analysis of an alternative T‐cell activation pathway , 1998, Immunological reviews.

[16]  Chika Morimoto,et al.  The structure and function of CD26 in the T‐cell immune response , 1998, Immunological reviews.

[17]  M. Hegen,et al.  Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function. , 1998, Molecular immunology.

[18]  M. Ditto,et al.  Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage , 1997, The Journal of experimental medicine.

[19]  Y. Bar-dayan,et al.  Thymic aging in ICR female mice is suspended by prolonged hydrocortisone exposure , 1997, Cell and Tissue Research.

[20]  B. Bodey,et al.  Involution of the mammalian thymus, one of the leading regulators of aging. , 1997, In vivo.

[21]  H. Mittrücker,et al.  The T-cell receptor associated zeta-chain is required but not sufficient for CD26 (dipeptidylpeptidase IV) mediated signaling. , 1997, Immunology letters.

[22]  M. Nagarkatti,et al.  Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. , 1997, Toxicology and applied pharmacology.

[23]  C. Abbott,et al.  Molecular analyses of human and rat dipeptidyl peptidase IV. , 1997, Advances in experimental medicine and biology.

[24]  M. Hegen,et al.  Structure of CD26 (dipeptidyl peptidase IV) and function in human T cell activation. , 1997, Advances in experimental medicine and biology.

[25]  U. Lendeckel,et al.  CD26/dipeptidyl peptidase IV in lymphocyte growth regulation. , 1997, Advances in experimental medicine and biology.

[26]  M. Ritter,et al.  Thymic involution with ageing: obsolescence or good housekeeping? , 1996, Immunology today.

[27]  P. Ruiz,et al.  Cytofluorographic evidence that thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny and apoptotic status. , 1996, Cytometry.

[28]  Y. Qiu,et al.  Immunoregulatory role of neurotransmitters. , 1996, Advances in Neuroimmunology.

[29]  B. Malissen,et al.  The cytoplasmic tail of the T cell receptor ζ chain is required for signaling via CD26 , 1995, European journal of immunology.

[30]  J. Bertherat,et al.  Neuroendocrine regulation of growth hormone. , 1995, European journal of endocrinology.

[31]  J. Sprent,et al.  T-cell apoptosis detected in situ during positive and negative selection in the thymus , 1994, Nature.

[32]  W. Savino,et al.  Control of thymus physiology by peptidic hormones and neuropeptides. , 1994, Immunology today.

[33]  R. Gerli,et al.  Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule. , 1994, Cellular immunology.

[34]  B. Fleischer,et al.  CD26: a surface protease involved in T-cell activation. , 1994, Immunology today.

[35]  G. Vanhoof,et al.  Binding of adenosine deaminase to the lymphocyte surface via CD26 , 1994, European journal of immunology.

[36]  Y. Bar-dayan,et al.  Effect of bovine growth hormone administration on the pattern of thymic involution in mice. , 1994, Thymus.

[37]  C. Morimoto,et al.  Direct association of adenosine deaminase with a T cell activation antigen, CD26. , 1993, Science.

[38]  V. Mukku,et al.  Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat. , 1993, Growth regulation.

[39]  J. Hadden,et al.  Thymic Involution in Aging Prospects for Correction , 1992, Annals of the New York Academy of Sciences.

[40]  W. Savino,et al.  In vivo effects of growth hormone on thymus function in aging mice , 1992, Brain, Behavior, and Immunity.

[41]  A. Globerson,et al.  Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow , 1992, Brain, Behavior, and Immunity.

[42]  G. Plowman,et al.  Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells , 1992, Journal of cellular physiology.

[43]  A. Globerson,et al.  Patterns of dual lymphocyte development in co-cultures of foetal thymus and lymphohaemopoietic cells from young and old mice. , 1992, Immunology.

[44]  E. Muñoz,et al.  CD26 induces T-cell proliferation by tyrosine protein phosphorylation. , 1992, Immunology.

[45]  E. Heimer,et al.  Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs. , 1992, Biochimica et biophysica acta.

[46]  K. Sakaguchi,et al.  Thymocyte costimulating antigen is CD26 (dipeptidyl-peptidase IV). Costimulation of granulocyte, macrophage, and T lineage cell proliferation via CD26. , 1992, Journal of immunology.

[47]  B. Seed,et al.  Cloning and functional expression of the T cell activation antigen CD26. , 1992, Journal of immunology.

[48]  P. Chanson,et al.  Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. , 1992, The Journal of clinical endocrinology and metabolism.

[49]  C. Caruso,et al.  The effect of age on mitogen responsive T cell precursors in human beings is completely restored by interleukin-2 , 1992, Mechanisms of Ageing and Development.

[50]  B. Bauvois,et al.  Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor‐α , 1992, European journal of immunology.

[51]  D. Frasca,et al.  Effect of synthetic thymic humoral factor (THF‐γ2) on T cell activities in immunodeficient ageing mice , 1992, Clinical and experimental immunology.

[52]  D. Marguet,et al.  cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases. , 1992, The Journal of biological chemistry.

[53]  P. Gluckman,et al.  Growth allometry of organs, muscles and bones in mice from lines divergently selected on the basis of plasma insulin-like growth factor-I. , 1992, Growth, development, and aging : GDA.

[54]  C. Morimoto,et al.  1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. , 1991, Journal of immunology.

[55]  C. Morimoto,et al.  Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. , 1991, Journal of immunology.

[56]  D. Marguet,et al.  Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV). , 1991, Journal of immunology.

[57]  A. Sartorio,et al.  Thymic endocrine activity in children with idiopathic growth-hormone deficiency. , 1991, The International journal of neuroscience.

[58]  Toshiyuki Tanaka,et al.  Molecular mechanisms underlying lymphocyte recirculation II. Differential regulation of LFA‐1 in the interaction between lymphocytes and high endothelial cells , 1991, European journal of immunology.

[59]  L. Lanfrancone,et al.  Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody. , 1990, Cellular immunology.

[60]  H. Binz,et al.  Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[61]  N. Letvin,et al.  1F7, a novel cell surface molecule, involved in helper function of CD4 cells. , 1989, Journal of Immunology.

[62]  P. Altevogt,et al.  Identical forms of the CD2 antigen expressed by mouse T and B lymphocytes , 1989, European journal of immunology.

[63]  L. Frohman,et al.  Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. , 1989, The Journal of clinical investigation.

[64]  D. Kioussis,et al.  Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice , 1989, Cell.

[65]  H. Macdonald,et al.  A novel T cell-activating molecule (THAM) highly expressed on CD4-CD8- murine thymocytes. , 1988, Journal of immunology.

[66]  D. Kioussis,et al.  The structure of the human CD2 gene and its expression in transgenic mice. , 1988, The EMBO journal.

[67]  F. Sánchez‐Madrid,et al.  Interaction between the CD45 antigen and phytohemagglutinin. Inhibitory effect on the lectininduced T cell proliferation by anti‐CD45 monoclonal antibody , 1987, European journal of immunology.

[68]  E. Reinherz,et al.  Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. , 1984, Journal of Immunology.

[69]  W. Vale,et al.  Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour , 1982, Nature.